Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MTL Cannabis ( (TSE:MTLC) ) has issued an update.
MTL Cannabis Corp., a licensed Canadian cannabis producer through its subsidiary Montréal Medical Cannabis Inc., operates a 57,000 square foot indoor cultivation facility and targets the regulated cannabis market.
The company announced that leading proxy advisory firms Institutional Shareholder Services and Glass Lewis have both recommended that MTL shareholders vote in favour of a proposed plan of arrangement under which Canopy Growth Corporation would acquire all outstanding MTL shares, offering each shareholder a mix of Canopy shares and cash at a premium to MTL’s unaffected share price, providing immediate liquidity and ongoing upside exposure to the combined business. MTL’s board, backed by an independent special committee and external advisors, has unanimously concluded the transaction is fair and in the best interests of shareholders, and is urging investors to support the deal at a special meeting on February 17, 2026, a step that, if approved, would further consolidate Canada’s cannabis sector and integrate MTL into a larger industry player.
More about MTL Cannabis
MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc., a licensed cannabis producer operating a 57,000 square foot indoor cultivation facility in Poin, focused on supplying regulated cannabis products to the Canadian market.
Average Trading Volume: 156,526
Technical Sentiment Signal: Hold
Current Market Cap: C$73.38M
Learn more about MTLC stock on TipRanks’ Stock Analysis page.